Cargando…
A Competent and Commercially Viable Process for the Synthesis of the Anti-Hypertensive Drug Olmesartan Medoxomil
Drug product purity and potency are of most significance in the regulatory market as we notice many recalled batches worldwide, particularly in the US and Japan. Olmesartan Medoxomil is an anti-hypertensive drug. The present invention relates to a process for the preparation of Olmesartan Medoxomil...
Autores principales: | Hanumantha Rao, Bommena, Subramanyeswara Rao, Inti Venkata, Ravi Kanth, Vysyaraju, Prasada Rao, Korrapati Venkata Vara, Balamurali Krishna, K., Syama Sundar, Bethanabatla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Austrian Journal of Pharmaceutical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727774/ https://www.ncbi.nlm.nih.gov/pubmed/26839831 http://dx.doi.org/10.3797/scipharm.1502-04 |
Ejemplares similares
-
Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
por: Greathouse, Mark
Publicado: (2006) -
Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
por: Rote, A. R., et al.
Publicado: (2010) -
Olmesartan medoxomil for the treatment of hypertension in children and adolescents
por: Tocci, Giuliano, et al.
Publicado: (2011) -
Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
por: Prajapati, Shailesh T., et al.
Publicado: (2013) -
Olmesartan medoxomil: Allergic reaction: case report
Publicado: (2022)